Ben Bishop is the CEO of Spirair, Inc., a medical technology company advancing minimally invasive, bioabsorbable implants for ENT conditions. He brings over two decades of leadership across leading medtech companies, having guided commercial launches and market development for innovative surgical and office-based devices.
Before joining Spirair, Ben held senior roles at Revelle Aesthetics, Revance Therapeutics, Arrinex, Cardinal Health, and Access Closure. At Spirair, he leads the company’s mission to help more patients breathe better through elegant, evidence-driven solutions for nasal and sinus care.
